Comparison of the therapeutic effect of intravenous infusion gamma globulin on Kawasaki disease by two different regimes
YANG Hai-Xia, ZHENG Min-Cui
Abstract No abstract available
Cite this article:
YANG Hai-Xia,ZHENG Min-Cui. Comparison of the therapeutic effect of intravenous infusion gamma globulin on Kawasaki disease by two different regimes[J]. 中国当代儿科杂志, 2004, 6(1): 57-58.
YANG Hai-Xia,ZHENG Min-Cui. Comparison of the therapeutic effect of intravenous infusion gamma globulin on Kawasaki disease by two different regimes[J]. CJCP, 2004, 6(1): 57-58.
URL:
http://www.zgddek.com/EN/ OR http://www.zgddek.com/EN/Y2004/V6/I1/57
[1]
CHEN Xiao-Yan, LIU Chao, WU Wen-Qi, ZHANG Ao-Li, LIU Li-Peng, LAN Yang, CAI Yu-Li, RUAN Min, ZHU Xiao-Fan. Efficacy and prognostic factors in children with non-core binding factor acute myeloid leukemia [J]. CJCP, 2020, 22(5): 466-472.
[2]
ZHANG Wei-Feng, CHEN Dong-Mei, WU Lian-Qiang, WANG Rui-Quan. Clinical effect of continuous blood purification in treatment of multiple organ dysfunction syndrome in neonates [J]. CJCP, 2020, 22(1): 31-36.
[3]
XIANG Hong, CHANG Ming, WANG Qiu-Xia, LU Hong-Yan. Changes in serum levels of adipokine after treatment in children with Kawasaki disease [J]. CJCP, 2020, 22(1): 53-57.
[4]
GONG Xiao-Yan, LI Bing-Fei. Clinical effect of carvedilol in treatment of children with severe hand-foot-mouth disease caused by enterovirus 71 infection [J]. CJCP, 2019, 21(8): 796-800.
[5]
LIU Yi-Ling, WANG Xian-Min, CHEN Ting-Ting, SHI Kun, LU Ya-Heng, GUO Yong-Hong, LI Yan. Clinical effect and safety of clopidogrel combined with aspirin in antithrombotic therapy for children with Kawasaki disease complicated by small/medium-sized coronary artery aneurysms [J]. CJCP, 2019, 21(8): 801-805.
[6]
XIAO Zhao-Hua, ZHANG Guo-Yuan, ZHENG Xiang-Rong. Pyrexia and hemoptysis for eight days in a school-age child [J]. CJCP, 2019, 21(6): 589-593.
[7]
ZHU Xiao-Hong, TU Jin-Wei, DAI Ji-Hong. Clinical effect of fluticasone propionate, montelukast sodium and ketotifen in treatment of cough variant asthma in children [J]. CJCP, 2019, 21(4): 393-398.
[8]
LIU Li-Ping, YUAN Yong-Hua, HE Xue-Hua, CHEN Min, PENG Dan-Xia, XU Wei, XIA Xiao-Hui, CAO You-De, WANG Sheng, ZHU Qian-Li. Expression of Nod-like receptor protein 3 inflammasome in peripheral blood mononuclear cells of children with Kawasaki disease in the acute stage [J]. CJCP, 2019, 21(10): 992-997.
[9]
CAI Ke, WANG Feng, GUI Yong-Hao. Research advances in the pathogenesis of familial Kawasaki disease [J]. CJCP, 2018, 20(7): 594-597.
[10]
ZHANG Xin-Yan, HE Ting, LING Jia-Yun, HU Xiu-Fen, WEN Yu, WEI Jun, LU Hui-Ling. Serum levels of interleukin-38 and interleukin-1β in the acute phase of Kawasaki disease in children [J]. CJCP, 2018, 20(7): 543-548.
[11]
HUANG Miao, DONG Guo-Qing, XIAO Fei, SU Yue-Yue, LI Ming-Zhu. Association of +45 and +276 polymorphisms in the adiponectin gene with the development of Kawasaki disease [J]. CJCP, 2018, 20(7): 549-553.
[12]
TIAN Fang, ZHANG Jing, XIAO Lan. Clinical features of children with Kawasaki disease aged over 5 years [J]. CJCP, 2018, 20(11): 917-920.
[13]
GUO Jing-Min, SHI Xiao-Xi, YANG Shi-Wei, QIAN Qin-Fang, HUANG Yan, XIE Yan-Qin, OU Ping. Efficacy of clonidine transdermal patch in treatment of moderate to severe tic disorders in children [J]. CJCP, 2017, 19(7): 786-789.
[14]
ZHU Xiang-Li, LIU Zheng, WU Zhong-Qiang, LI Dong, JIANG Ai-Ping, YU Gui-Xia. Clinical effects of different therapeutic regimens for Helicobacter pylori infection in children [J]. CJCP, 2017, 19(6): 672-676.
[15]
LI Yu-Wen, HU Yu-Hua, ZHU Tian-Tian, CHU An-Zhen, ZHU Chuan-Long. Clinical efficacy of compound glycyrrhizin tablets in the treatment of children with nonalcoholic fatty liver disease [J]. CJCP, 2017, 19(5): 505-509.